06/28/2024 | Press release | Distributed by Public on 06/28/2024 05:34
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 25, 2024, Lexeo Therapeutics, Inc. (the "Company") held its virtual 2024 Annual Meeting of Stockholders (the "Annual Meeting") exclusively online via live webcast. The stockholders voted on the following proposals at the Annual Meeting:
Proposal 1. Election of Class I Director
The Company's stockholders elected the person listed below as the Class I Director, to serve until the Company's 2027 Annual Meeting of Stockholders and until her successor is elected and qualified, or until her earlier death, resignation or removal. The final voting results are as follows:
FOR |
WITHHELD |
BROKER NON-VOTE |
|
Mette Kirstine Agger |
14,499,254 |
7,450,057 |
1,249,160 |
Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm
The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The final voting results are as follows:
FOR |
AGAINST |
ABSTAIN |
|
23,194,982 |
3,088 |
401 |
For more information about the foregoing proposals, see the Proxy Statement as filed with the Securities and Exchange Commission on April 26, 2024.